TD Cowen reiterates Hold on ChargePoint stock, cites EBITDA path

ChargePoint beat Q2 expectations with revenue of $116M (vs. $105.43M forecast) and narrowed its adjusted loss to $1.35/share from the projected $1.60. Gross margin expanded to a record 38% non-GAAP (35% ex-tariff refunds) and the adjusted EBITDA loss improved to $5M from $19M, with essentially zero cash burn and $96M in cash. TD Cowen reiterated a Hold and sees improved visibility toward positive EBITDA, while acknowledging Q3 revenue guidance is less robust but still above consensus.

Analysis

CHPT’s real signal is not the headline beat; it’s that the company is getting closer to proving the sector can survive without serial dilution. In a capital-intensive network business, a credible path to self-funding is worth more than a one-quarter EBITDA inflection because it lowers the probability of a financing overhang and raises the odds of consolidation on favorable terms. That should support the higher-quality charging names first, while weaker peers with slower margin repair and tighter liquidity stay under pressure.

The market may be overweighting the optics of EBITDA improvement and underweighting cash conversion. If the next 1-2 quarters show positive adjusted EBITDA but free cash flow remains negative, the stock can still rerate lower once the print fades, because the core question is whether utilization is rising fast enough to absorb maintenance capex and working capital. The vulnerable group is the smaller, more levered charging platforms where any improvement in industry sentiment could paradoxically make financing easier for the weakest names, extending competition rather than eliminating it.

Contrarian view: the consensus is treating this as a clean EV-thesis read-through, but the more important second-order effect is pricing power. If CHPT is improving mainly through cost cuts and inventory normalization, not accelerating network utilization, the margin story is fragile. For the thesis to break, watch for a re-acceleration in cash burn, a flat or down quarter in gross margin ex-one-offs, or any need for external capital over the next 6-12 months.

Key Decisions for Investors

• Tactical only: buy CHPT on post-gap pullbacks, not strength-chase, with a 1-3 month target for a squeeze on continued margin/cash-burn improvement; cut if the stock gives back the earnings gap and management fails to reiterate self-funding.
• Pair trade: long CHPT / short EVGO or BLNK over 1-3 months. CHPT has the cleaner balance-sheet and margin trajectory, while the weaker names remain more exposed to financing risk if sector enthusiasm cools.
• Take profits into any sharp CHPT rally above the post-earnings move; the setup is better for a tactical trade than a structural long until free cash flow turns positive for multiple quarters.
• Watch item: if CHPT delivers two consecutive quarters of positive adjusted EBITDA but remains materially FCF-negative, fade the rerating and rotate out of the name.